Clinical Trials

Showing trials with last updates posted in 2022.

NCT02071862 | COMPLETED | PHASE1
210 participants

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2022-07-20
Start Date:
2014-02-28
Completion:
2019-03-31
Conditions
  • Solid Tumors
  • Triple-Negative Breast Cancer
  • Non Small Cell Lung Cancer
  • Renal Cell Carcinoma
  • Mesothelioma
  • Fumarate Hydratase (FH)-Deficient Tumors
  • Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST)
  • Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors
  • Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations
  • Tumors Harboring Amplifications in the cMyc Gene
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page